GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,989,000 | -21.0% | 206,363 | -20.0% | 1.21% | -25.9% |
| Q4 2021 | $11,376,000 | -41.9% | 257,962 | -49.7% | 1.63% | -39.2% |
| Q3 2021 | $19,595,000 | -4.0% | 512,815 | 0.0% | 2.68% | -2.3% |
| Q2 2021 | $20,420,000 | -0.6% | 512,815 | -10.9% | 2.75% | -11.0% |
| Q1 2021 | $20,548,000 | -3.0% | 575,741 | 0.0% | 3.08% | -15.8% |
| Q4 2020 | $21,187,000 | +24.9% | 575,741 | +27.7% | 3.66% | -8.2% |
| Q3 2020 | $16,966,000 | – | 450,741 | – | 3.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |